U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952816) titled 'Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure' on April 08.
Brief Summary: Currently, there is no holistic solution for patients with respiratory diseases that includes oxygenation and management of a patient with respiratory disease, combining dynamic and automatic O2 administration and the detection of clinical worsening, generating a diagnostic suspicion, a management proposal, and notifying the medical team.
For device validation, prospective studies will be conducted in patients in respiratory intermediate care units, conventional hospitalization, during physical activity in the hospital settin...